Jaguar Health, Inc. Business Finance Contracts & Agreements

221 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers dated May 20, 2025
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Placement Agent Common Stock Purchase Warrant between Jaguar Health, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2025)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 14, 2025)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. for Series J to Series L Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Exchange Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P. (May 13, 2025)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2025
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (February 2025)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Waiver to Securities Purchase Agreement between Jaguar Health, Inc. and Buyers (May 2025)
Waiver Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Registration Rights Agreement between Jaguar Health, Inc. and Buyers (March 26, 2025)
Registration Rights Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Securities Purchase Agreement between Jaguar Health, Inc. and Buyers (March 26, 2025)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Jaguar Health, Inc. Convertible Promissory Note Issued to Investor under Securities Purchase Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Amendment to At The Market Offering Agreement among Jaguar Health, Ladenburg Thalmann & Co., and Lucid Capital Markets (November 2024)
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Amendment to At The Market Offering Agreement between Jaguar Health, Inc. and Ladenburg Thalmann & Co., Inc. (May 23, 2024)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Exchange Agreement between Jaguar Health, Inc. and Investor for Warrant-for-Share Exchange
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2024
Exchange Agreement between Streeterville Capital, LLC and Jaguar Health, Inc. (March 1, 2024)
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2024
Exchange Agreement between Uptown Capital, LLC and Jaguar Health, Inc. for Series I Convertible Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 1 to Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Uptown Capital, LLC
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Global Amendment No. 2 to Royalty Interest Agreement between Jaguar Health, Inc. and Iliad Research and Trading, L.P.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Memorandum of Understanding Modifying Warrant Allocation under Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, Iliad Research, Uptown Capital, and Streeterville...
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
First Amendment to Standstill Agreement among Jaguar Health, Napo Pharmaceuticals, and Investors
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Exchange Agreement between Jaguar Health, Inc. and Lender for Partitioned Royalty and Series H Convertible Preferred Stock
Exchange Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Standstill Agreement among Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Investors (Iliad, Uptown, Streeterville) dated May 8, 2023
Forbearance Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2023
Securities Purchase Agreement between Jaguar Health, Inc. and Purchasers (May 2023)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2023
Jaguar Health, Inc. Stock Option Cancellation Agreement with Optionholder
Stock Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2022
Securities Purchase Agreement between Jaguar Health, Inc. and Purchaser (Series F Preferred Stock)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment to Secured Promissory Note and Note Purchase Agreement by and among Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Royalty Interest Purchase Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC (August 24, 2022)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Royalty Interest Agreement between Jaguar Health, Inc. and Streeterville Capital, LLC dated August 24, 2022
Financing Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2022
Securities Purchase Agreement between Jaguar Health, Inc. and Purchaser (Series E Preferred Stock)
Purchase Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2022
Global Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Global Amendment to Royalty Interest Agreement between Streeterville Capital, LLC and Jaguar Health, Inc.
Modification Agreements
Jaguar Health, Inc.
Pharmaceuticals
2022
Placement Agent Common Stock Purchase Warrant between Jaguar Health, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2025)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Amendment to At The Market Offering Agreement Among Jaguar Health, Inc., Ladenburg Thalmann & Co. Inc., and Lucid Capital Markets, LLC (July 17, 2024)
Equity Distribution Agreements
Jaguar Health, Inc.
Pharmaceuticals
2024
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2023)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023
Common Stock Purchase Warrant Agreement between Jaguar Health, Inc. and Holder (2023)
Warrant Agreements
Jaguar Health, Inc.
Pharmaceuticals
2023